| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | -0.19 | 0.01 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | -0.089 | 0.01 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.01 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | -0.073 | 0.01 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | -0.078 | 0.01 |
| mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | -0.08 | 0.01 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.11 | 0.01 |
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | -0.41 | 0.01 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | -0.077 | 0.01 |
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.02 |